NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/24/2026
Back to search
Official data from USPTO
TOUCHLIGHT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TOUCHLIGHT
ST13
US500000099041690Class
1, 5, 9, 40, 42
Filing
99041690
Registration
8148424
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
02/25/2026
Trademark type
Word
Nice classes
1, 5, 9, 40, 42
Filing date
02/14/2025
Registration date
02/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/24/2026
Last transaction
02/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Hampton, GB
Examiner
KEAM, ALEX S
Law office
O60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Touchlight IP Limited
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalsenzymesnucleic acid constructs and viral vectors for scientific and research use; nucleic acid constructs and viral vectors for use in the manufacture of nucleic acids; nucleic acid constructs and viral vectors for manufacturing viruses; nucleic acid constructs and viral vectors for use in scientific researchagribiotechnologynanotechnology; two-dimensional and three-dimensional nucleic acid constructs for creating nanostructures and scaffolds; all of the aforementioned goods not for medical or veterinary use
Class 5
Nucleic acid constructs for medical and veterinary purposes; nucleic acid constructs and viral vectors for use as prophylactic or therapeutic vaccines; nucleic acid constructs and viral vectors for the production of prophylactic or therapeutic vaccines; nucleic acid constructs and viral vectors for medical use; nucleic acid constructs and viral vectors for the production of therapeutic or prophylactic viruses; nucleic acid constructs and viral vectors for gene therapy; nucleic acid constructs and viral vectors for use in cell therapy; nucleic acid constructs and viral vectors for use in genome editing; nucleic acid constructs and viral vectors for use in therapy
Class 9
Apparatus and instruments for the manufacture and processing of nucleic acid constructsDNA amplification apparatus and instruments for scientific and research purposes; nucleic acid constructs comprising natural and unnatural nucleotidesnucleic acid amplification apparatus for scientific purposes; nucleic acid constructs comprising synthetic backbones or a mixture of natural and synthetic backbonesnucleic acid amplification apparatus for scientific purposes; composites of nucleic acid constructs with organic and inorganic chemicalsnucleic acid amplification apparatus for scientific purposes; all the aforesaid goods for use in nanotechnology applications including data storagedata retrieval and computing; electronic components in the form of electrical wiressemi-conductorstransistorsrectifiersdiodeslight emitting diodes (LEDs)systems for energy storagebatteriesall containing nucleic acid constructs; apparatus that uses nucleic acid constructs for labelingimagingsensing applications for scientific research purposes; nucleic acid constructs as smart materialsbeing components of devices used for labelingimaging and sensing DNA sequences for scientific research purposes; replacement parts for all the aforesaid technology
Class 40
Treatment of nucleic acid constructs; manufacture for others of nucleic acid constructs; manufacture for others of nucleic acids; manufacture for others of viruses; manufacture for others of vectors; manufacture for others of medical and veterinary therapiesvaccinesprophylacticscounteragents; manufacture for others of nucleic acid constructs for nanotechnology applications; manufacture for others of nucleic acid constructs for labelingimagingsensing applications; manufacture for others of nucleic acid constructs for electronic components; consultancy relating to the custom manufacture of the aforementioned goods
Class 42
Scientific and technological servicesresearch and design in the fields of chemicalsenzymesnucleic acid constructsviral vectors; chemical and biological analysis and research services; research into nucleic acids and nucleic acid constructs; research and development into the creation of nucleic acid constructs; researchanalysisdesigndevelopment relating to therapiesprophylacticscounteragents based on nucleic acid constructs; research and development in the fields of gene therapydiagnostic preparationagribiotechnologynanotechnology; consultancy relating to the aforesaid services
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/24/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/06/2026
PUBO
PUBLISHED FOR OPPOSITION
01/06/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/31/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/08/2025
ATRV
ATTORNEY REVIEW COMPLETED
12/08/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
12/08/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/08/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
12/08/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/08/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/21/2025
GNFR
FINAL REFUSAL E-MAILED
10/21/2025
CNFR
FINAL REFUSAL WRITTEN
10/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/29/2025
GNRT
NON-FINAL ACTION E-MAILED
07/29/2025
CNRT
NON-FINAL ACTION WRITTEN
07/29/2025
DOCK
ASSIGNED TO EXAMINER
07/22/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/09/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/25/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/25/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/25/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/25/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/14/2025
NWAP
NEW APPLICATION ENTERED
02/14/2025
Continuous trademark protection
Get notified about every new filing that threatens TOUCHLIGHT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.